Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future.
Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future.
The global Neuroleptics Market is estimated to reach USD 15.84 Billion by 2028, according to a new report by Reports and Data. This can be mainly associated with the rising incidence of psychosis and other related diseases. The major factors responsible for the rising incidence of these disorders include substance-induced psychoses, genetic mutations, and physical illness that lead to depression. Growing drug abuse, addiction to Neuroleptics drugs and over prescription of drugs are also some of the notable factors that are contributing to the growth of the market. Additional factors such as high investments in research and development and the introduction of new and developed Neuroleptics compounds are expected to stimulate the market growth further.
Anti-psychotic drugs, also called neuroleptics or tranquilizers, are a particular type of medication that is used for treating schizophrenia or bipolar disorder mostly. They are used to treat psychosis, including delusions, hallucinations, and disordered thought of paranoia, among others. These drugs prevent the dopamine receptors in the dopaminergic pathways of the brain, by controlling the effect of dopamine, which is directly connected to the psychotic encounters. The growing predominance of mental illness meanwhile has led to massive consumption of Neuroleptics. National Alliance of Mental Illness conducted a research in 2015 which says, 1 in 5 adults is experiencing mental issues. However, use of these drugs for a long time can result in side effects like involuntary movement disorder and metabolic syndrome, eventually leading to rising mortality in the population with dementia.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1282
North America accounts for the largest market share of 22.30% in 2020. It is expected to grow at a CAGR of 1.81% during the forecast period. Many people with physical disorders suffer from co-occurring disorders. An increasing predominance of mental health disorders, such as bipolar disorder and schizophrenia, is driving the growth of the Neuroleptics market in North America.
Further key findings from the report suggest
- Neuroleptics drugs are used as medicines to treat severe mental health conditions such as psychosis as well as other mental and emotional disorders. They are also prescribed to treat pain and stubborn hiccoughs that can occur from restlessness during palliative care.
- It helps to manage the symptoms of psychosis along with less severe mental health conditions such as mood and bipolar disorder that may grow into later psychosis. These drugs decrease or increase the impact of neurotransmitters in the brain to regulate levels according to the need. Neurotransmitters help to transfer information throughout the brain. The neurotransmitters affected include noradrenaline, dopamine, and serotonin.
- Psychosis is a critical mental condition where a patient loses contact with reality. The disease often includes delusions or hallucinations. The patient may often hear voices and sounds that aren’t there when encountering hallucinations, while delusions related to psychosis involves perceptions or thoughts that aren’t based on reality.
- Schizophrenia under the disease segment accounts for the largest market share of 39.30% in 2020. It is a type of mental disorder described by false thinking, hearing imaginary voices, the decrease in social engagement, and absence of motivation.
- A person with schizophrenia can also suffer from other mental health problems such as major depressive disorder (MDD), anxiety disorder, and substance use disorder.
- The Depression sector of the disease segment accounts for the second largest share of 32.20% in 2020 and is one of the major factors that are driving the market growth.
- The second generation accounts for the largest share of 37.86% in 2020. It is also known as atypical Neuroleptics that include risperidone, paliperidone, clozapine, asenapine, sertindole, olanzapine, quetiapine. These are used for the treatment of schizophrenia and have swiftly begun replacing the older, first-generation Neuroleptics.
- Second generation product are also known as atypical agents. They act as broad-spectrum antagonists of dopamine, alpha-noradrenergic and serotonin receptors.
- The market players are primarily focused on developing new technologies to meet the requirements of users. Various companies are also involved in numerous merger & acquisitions as their essential strategy is to maintain sufficient market share. These factors are expected to have a positive impact on industry growth over the next few years.
- Key participants include AstraZeneca, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, Alkermes, Actavis Generics, Bristol-Myers Squibb, Allergen, Otsuka and Pfizer.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/neuroleptics-market
For the purpose of this report, Reports and Data have segmented global Neuroleptics Market on the basis of Product, End User, Disease, and region:
End User Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2020-2028 )
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Product Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2020-2028 )
- First-generation Drugs
- Second-generation Drugs
- Third-generation Drugs
Disease Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2020-2028 )
- Schizophrenia
- Unipolar Depression
- Bipolar Disorder
- Dementia
- Others
Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/1282
Regional Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028 )
- North America
- U.S.
- Europe
- UK
- France
- Asia Pacific
- China
- India
- Japan
- Middle East & Africa
- Latin America
Brazil
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1282
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Soft Tissue Sarcoma Treatment Market By Treatment (Chemotherapy, Targeted Therapy, Anti-angiogenesis Drugs, Radiation Therapy, Surgery), By End-use (Hospitals, Oncology Centers, Long Term Care Centers), and By Region Forecast To 2028
Over the Counter/OTC Test Market By Product Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-abuse Tests, Other Tests), By Technology (Immunoassays, Lateral Flow Assays, Dipsticks), and By Region Forecast To 2028
Microplate Market By Product (Microplate Readers, Microplate Pipetting Systems & Dispensers, Microplate Washers, Microplate Accessories & Software), By Application (Drug Discovery, Clinical Diagnostics), By End-use (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes), and By Region Forecast to 2028
Hernia Repair Device Market Size, Share And Industry Analysis By Product Type (Biologic Mesh, Synthetic Mesh, Sutures, Tack Applicators, and Glue Applicators), By Surgery Type (Inguinal Hernia, Umbilical Hernia, Incisional Hernia, Femoral Hernia, and Others), and By Region Forecast To 2028
Polycystic Kidney Disease Treatment Market Size, Share And Industry Analysis By Type (Autosomal Dominant Polycystic Kidney Disease (ADPKD), Autosomal Recessive Polycystic Kidney Disease (ARPKD)), By Distribution Channels (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/report-detail/neuroleptics-market